ABSI Long Put Strategy
ABSI (Absci Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
ABSI (Absci Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.56B, a beta of 2.43 versus the broader market, a 52-week range of 2.24-12.055, average daily share volume of 5.1M, a public-listing history dating back to 2021, approximately 140 full-time employees. These structural characteristics shape how ABSI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.43 indicates ABSI has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long put on ABSI?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
ABSI snapshot
As of August 14, 2026, spot at $9.10, ATM IV 108.00%, IV rank 58.48%, expected move 30.96%. The long put on ABSI below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 7-day expiry.
Why this long put structure on ABSI specifically: ABSI IV at 108.00% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 30.96% (roughly $2.82 on the underlying). The 7-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ABSI expiries trade a higher absolute premium for lower per-day decay. Position sizing on ABSI should anchor to the underlying notional of $9.10 per share and to the trader's directional view on ABSI stock.
ABSI long put setup
The ABSI long put below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ABSI at $9.10 on that close, the first option leg uses a $9.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ABSI chain at a 7-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ABSI shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $9.00 | $0.53 |
ABSI long put risk and reward
- Net Premium / Debit
- -$52.50
- Max Profit (per contract)
- $846.50
- Max Loss (per contract)
- -$52.50
- Breakeven(s)
- $8.48
- Risk / Reward Ratio
- 16.124
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
ABSI long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on ABSI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | +$846.50 |
| $2.02 | -77.8% | +$645.40 |
| $4.03 | -55.7% | +$444.31 |
| $6.04 | -33.6% | +$243.21 |
| $8.05 | -11.5% | +$42.12 |
| $10.06 | +10.6% | -$52.50 |
| $12.08 | +32.7% | -$52.50 |
| $14.09 | +54.8% | -$52.50 |
| $16.10 | +76.9% | -$52.50 |
| $18.11 | +99.0% | -$52.50 |
When traders use long put on ABSI
Long puts on ABSI hedge an existing long ABSI stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying ABSI exposure being hedged.
ABSI thesis for this long put
The market-implied 1-standard-deviation range for ABSI extends from approximately $6.28 on the downside to $11.92 on the upside. A ABSI long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long ABSI position with one put per 100 shares held. Current ABSI IV rank near 58.48% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on ABSI should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ABSI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ABSI-specific events.
ABSI long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ABSI positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ABSI alongside the broader basket even when ABSI-specific fundamentals are unchanged. Long-premium structures like a long put on ABSI are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ABSI chain quotes before placing a trade.
Frequently asked questions
- What is a long put on ABSI?
- A long put on ABSI is the long put strategy applied to ABSI (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With ABSI stock at $9.10 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed ABSI chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ABSI long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the ABSI long put priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 108.00%), the computed maximum profit is $846.50 per contract and the computed maximum loss is -$52.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ABSI long put?
- The breakeven for the ABSI long put priced on this page is roughly $8.48 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ABSI market-implied 1-standard-deviation expected move in the same options snapshot is approximately 30.96%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on ABSI?
- Long puts on ABSI hedge an existing long ABSI stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying ABSI exposure being hedged.
- How does current ABSI implied volatility affect this long put?
- ABSI ATM IV is at 108.00% with IV rank near 58.48%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.